The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 23, 2020

Filed:

Jan. 29, 2018
Applicant:

Hyperbranch Medical Technology, Inc., Durham, NC (US);

Inventors:

Kenneth E. Stockman, Raleigh, NC (US);

Michael A. Carnahan, Durham, NC (US);

Keith R. D'Alessio, Cary, NC (US);

Mark W. Grinstaff, Brookline, MA (US);

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/74 (2006.01); A61L 26/00 (2006.01); A61K 31/785 (2006.01); A61K 31/787 (2006.01); A61L 27/18 (2006.01); A61L 24/04 (2006.01); A61L 24/00 (2006.01); A61L 27/26 (2006.01); A61L 27/52 (2006.01); A61L 27/56 (2006.01); A61B 17/00 (2006.01); A61K 51/12 (2006.01);
U.S. Cl.
CPC ...
A61L 26/0019 (2013.01); A61K 31/785 (2013.01); A61K 31/787 (2013.01); A61L 24/0031 (2013.01); A61L 24/0036 (2013.01); A61L 24/043 (2013.01); A61L 24/046 (2013.01); A61L 26/008 (2013.01); A61L 26/0052 (2013.01); A61L 26/0085 (2013.01); A61L 27/18 (2013.01); A61L 27/26 (2013.01); A61L 27/52 (2013.01); A61L 27/56 (2013.01); A61B 2017/0065 (2013.01); A61B 2017/00951 (2013.01); A61K 51/1279 (2013.01);
Abstract

One aspect of the present invention generally relates to methods of sealing a wound or tissue plane or filling a void splace. In a preferred embodiment, the wound is an ophthalmic, pleural or dural wound. In certain instances, the compositions used to seal the wound or tissue plane comprises a polyalkyleneimine. In a preferred embodiment, the polyalkyleneimine is polyethyleneimine. Treatment of the polyethyleneimine with a cross-linking reagent causes the polyethyleneimine polymers to polymerize forming a seal. In certain instances, the cross-linking reagent is a polyethylene glycol having reactive terminal groups. In certain instances, the reactive terminal groups are activated esters, such as N-hydroxy succinimide ester. In certain instances, the reactive terminal groups are isocyanates. In certain instances, the polyethyleneimine has a lysine, cysteine, isocysteine or other nucleophilic group attached to the periphery of the polymer. In certain instances, the polyethyleneimine is mixed with a second polymer, such as a polyethylene glycol containing nucleophilic groups. In certain instances, the compositions used to seal the wound or tissue plane are formed by reacting a polyalkyleneimine bearing electrophilic groups with a cross-linking reagent containing nucleophilic groups. In certain instances, the electrophilic groups on the polyalkyleneimine are activated esters, such as N-hydroxy succinimide ester. In certain instances, the compositions used to seal the wound or tissue plane are formed by reacting a polyalkyleneimine bearing photopolymerizable groups with ultraviolet or visible light. Compositions used to seal the wound which contain PEI or a derivative of PEI are found to adhere tightly to the tissue. Other aspects of the present invention relate to methods of filling a void of a patient or adhering tissue. In certain instances, the methods use a polyalkyleneimine. In a preferred embodiment, the polyalkyleneimine is polyethyleneimine. Another aspect of the present invention relates to a polymeric composition formed by exposing a polyalkyleneimine to an activated polyalkylene glycol. In certain instances, the composition is attached to mammalian tissue.


Find Patent Forward Citations

Loading…